论文部分内容阅读
生血康口服液对荷瘤 (S180 )小鼠、正常动物接受化疗 (环磷酰胺、丝裂霉素 )及荷瘤 (U14 )小鼠、正常小鼠接受60 Co照射所致外周血白细胞和血红蛋白降低有显著的对抗作用 ;对正常动物化疗引起的骨髓有核细胞及脾脏重量降低有显著的对抗作用 ;对荷瘤 (S180 )小鼠腹水癌的动物存活时间有一定的延长作用。
Shengxuekang Oral Liquid receives peripheral blood leukocytes and hemoglobin due to 60 Co irradiation in tumor-bearing (S180) mice, normal animals receiving chemotherapy (cyclophosphamide, mitomycin), tumor-bearing (U14) mice, and normal mice. The reduction has a significant antagonistic effect; it has a significant antagonistic effect on the reduction of bone marrow nucleated cells and spleen weight caused by chemotherapy in normal animals; and has a prolonged effect on the survival time of tumor-bearing (S180) mouse ascites carcinoma.